What is the Role of Nitric Oxide in Murine and Human Host Defense against Tuberculosis?
- 1 November 2001
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 25 (5) , 606-612
- https://doi.org/10.1165/ajrcmb.25.5.4487
Abstract
The production of reactive oxygen intermediates and reactive nitrogen intermediates by innate immune cells is considered to be an effective host-defense mechanism against microbial pathogens. In the murine model of tuberculosis (TB), nitric oxide (NO) plays an essential role in the killing of Mycobacterium tuberculosis by mononuclear phagocytes. For example, in the mouse strain with a genetic disruption for inducible NO synthase (iNOS-/-), infection with M. tuberculosis is associated with a significantly higher risk of dissemination and mortality. Although more controversial in humans, there is a growing body of evidence that NO produced by TB-infected macrophages and by epithelial cells also has antimycobacterial effects against M. tuberculosis. The precise mechanism(s) by which NO and other reactive nitrogen species antagonize M. tuberculosis is not known, but may involve disruption of bacterial DNA, proteins, signaling, and/or induction of apoptosis of macrophages that harbor mycobacteria. In addition to cytokines such as tumor necrosis factor-alpha and interleukin 1-beta, mycobacterial cell wall components such as lipoarabinomannan and 19 kD lipoprotein, along with the T-cell-derived interferon-gamma, may also induce NO expression. In a Darwinian fashion, it also appears that certain strains of M. tuberculosis have evolved strategies to combat the toxic effects of NO.Keywords
This publication has 83 references indexed in Scilit:
- Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogensProceedings of the National Academy of Sciences, 2000
- Genetic, Biochemical, and Clinical Features of Chronic Granulomatous DiseaseMedicine, 2000
- Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anionTubercle and Lung Disease, 1999
- In-vitro synergy of paromomycin with metronidazole alone or metronidazole plus hydroxymetronidazole against Helicobacter pylori.Journal of Antimicrobial Chemotherapy, 1999
- Induction of Apoptosis in Murine Macrophages byMycobacterium tuberculosisIs Reactive Oxygen Intermediates-IndependentBiochemical and Biophysical Research Communications, 1998
- The Role of Phagocytic Respiratory Burst in Host Defense Against Mycobacterium tuberculosisClinical Infectious Diseases, 1998
- Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic miceTubercle and Lung Disease, 1997
- Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.The Journal of Experimental Medicine, 1992
- Killing of Mycobacterium tuberculosis by Neutrophils: A Nonoxidative ProcessThe Journal of Infectious Diseases, 1990
- Chronic Granulomatous DiseasePediatric Clinics of North America, 1977